scholarly journals Sane and safe: Forced social distancing to prevent human-to-human transmission of COVID-19

2021 ◽  
Vol 16 (1) ◽  
pp. 15-17
Author(s):  
Firdous Jahan
Keyword(s):  
Respiratory Tract ◽  
Sore Throat ◽  
Respiratory Tract Infections ◽  
High Grade ◽  
Wild Animals ◽  
High Grade Fever ◽  
Current Outbreak ◽  
Global Concern ◽  
Tract Infections ◽  
The City

The current outbreak of COVID-19, originating from the city of Wuhan in China and ultimately involving over 200 countries, is now a global concern. Evidence indicates that COVID-19 spread to humans from wild animals, causing severe respiratory tract infections in humans; the typical symptoms of COVID include cough, high-grade fever, sore throat, and difficulty in breathing. The infection spreads from human to human via droplets. Therefore, social or physical distancing can reduce spread within communities. Asymptomatic spread can also occur during family gatherings or in the workplace; thus, we must enforce physical distancing as much as possible to reduce the spread of cases.

Upper respiratory tract infections

2010 ◽  
pp. 3227-3231 ◽  
Author(s):  
P. Little
Keyword(s):  
Respiratory Tract ◽  
Sore Throat ◽  
Respiratory Tract Infections ◽  
Medical Advice ◽  
Upper Respiratory Tract Infections ◽  
Upper Respiratory Tract ◽  
Cervical Lymph Nodes ◽  
The United Kingdom ◽  
Upper Respiratory ◽  
Tract Infections

Acute upper respiratory tract infections (URTIs) are the commonest reason for patients to seek medical advice in the United Kingdom. Pharyngitis/tonsillitis—this is caused by both bacterial and viral organisms, with sore throat often accompanied by fever, headache, and other symptoms, with or without enlarged and tender cervical lymph nodes, tonsillar erythema, and exudate. Investigations are not generally performed or required. Antibiotics have modest benefit, so for patients who are not unwell systemically the physician should either not prescribe, or use a delayed prescribing approach, advising the patient to wait for several days before collecting or using their prescription. The antibiotic of choice is probably penicillin V, with a short acting macrolide the second-line agent. The benefits of tonsillectomy in preventing recurrent sore throat are modest....

scholarly journals FOOD SAFETY MANAGEMENT IN LIGHT OF PANDEMIC COVID-19FOR MEDIUM CARE POSITIVE CASES UNIT(MCU)AT 57357CCHE

2021 ◽  
Vol 9 (02) ◽  
pp. 953-960
Author(s):  
Afaf A. Amin ◽  
◽  
Gulsen A. Saleh ◽  
Ahmed S. Khedr ◽  
◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Safety Management ◽  
The Other ◽  
World Health ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Tract Infections ◽  
The City

COVID-19 is a new strain of coronavirus to which humans have not got immunity. It originated in China and has quickly spread around the world.It is a disease caused by an infection by SARS-CoV-2 virus, first identified in the city of Wuhan, in Chinas Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020. Like the other coronaviruses, the SARS-CoV-2 virus primarily causes respiratory tract infections, and the severity of the COVID-19 disease can range from mild to fatal.

scholarly journals Drugs used for the treatment of COVID-19: A Review

2021 ◽  
Vol 16 (1) ◽  
pp. 45-51
Author(s):  
MM Bodiuzzaman
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Tract ◽  
Respiratory Distress Syndrome ◽  
Respiratory Tract Infections ◽  
Distress Syndrome ◽  
Empirical Therapy ◽  
World Health ◽  
Health Organization ◽  
Tract Infections ◽  
The City

COVID-19 is primarily a respiratory disease caused by a newly discovered SARS-CoV-2 virus and identified in the city of Wuhan, China in December 2019. World Health Organization (WHO) has declared this disease as a pandemic, and warned other countries. Presently this has affected 221 countries, areas or territories worldwide, Spreading of this disease is very fast in USA, India, Brazil, and Russia than in the country of its origin China. Like other coronaviruses, this may develop respiratory tract infections in the patients range from mild to fatal illness like pneumonia and acute respiratory distress syndrome (ARDS). Bangladesh, a country of 170 million people, is not an exception regarding COVID-19; it has been reported 5,70,800 confirmed cases with 8690 documented deaths. Still now no effective drug, vaccine, or any procedure is available and experiments are underway. However, empirical therapy is being followed to manage and save the lives of the patients. There is a need for pharmacological alternatives to combat this deadly virus and its complications. Based on the previous experiences with similar coronavirus management and present preliminary data from uncontrolled studies, drugs like Chloroquine, Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, and Favipiravir have been recommended by the researchers to manage COVID-19. This review had assessed the potential mechanisms, safety profile, availability and cost of these drugs. This review concludes that the drugs mentioned above are having different properties and act differently in combating the COVID-19 viruses. Faridpur Med. Coll. J. 2021;16(1):45-51

Sign in / Sign up

Export Citation Format

Share Document